Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
(Korea AND ("Novel Coronavirus" OR COVID-19 OR SARS-CoV-2 OR 2019-nCoV))
323 results
  • COVID-19 and veterinarians for one health, zoonotic- and reverse-zoonotic transmissions. [Journal Article]
    J Vet Sci. 2020 May; 21(3):e51.Yoo HS, Yoo D
  • A novel coronavirus emerged in human populations and spread rapidly to cause the global coronavirus disease 2019 pandemic. Although the origin of the associated virus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) remains unclear, genetic evidence suggests that bats are a reservoir host of the virus, and pangolins are a probable intermediate. SARS-CoV-2 has crossed the species bar…
  • Empirical Treatment and Prevention of COVID-19. [Review]
    Infect Chemother. 2020 Jun 01 [Online ahead of print]Shin HS
  • The rapid spread of severe acute respiratory coronavirus syndrome 2 (SARS-CoV-2) in the population and throughout the cells within our body has been developing. Another major cycle of coronavirus disease 2019 (COVID-19), which is expected in the coming fall, could be even more severe than the current one. Therefore, effective countermeasures should be developed based on the already obtained clini…
  • Long-term surveillance of bat coronaviruses in Korea: Diversity and distribution pattern. [Journal Article]
    Transbound Emerg Dis. 2020 May 30 [Online ahead of print]Lo VT, Yoon SW, … Kim HK
  • Bats harbor diverse coronaviruses (CoVs), some of which are associated with zoonotic infections, as well as interspecies transmission. In this study, a total of 512 bat fecal samples from the bat habitats at different geographical locations in South Korea were investigated between 2016 and 2019. Seventy-eight samples were positive for coronaviruses (15.2%), comprising 68 alphacoronaviruses (13.3%…
  • Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy. [Case Reports]
    Int J Infect Dis. 2020 May 26 [Online ahead of print]Jang S, Rhee JY
  • No effective treatment for COVID-19 has been well established yet. Nafamostat, known as anticoagulant, has potential anti-inflammatory and anti-viral activities against COVID-19. We report three cases of COVID-19 pneumonia who progressed while using antiviral drugs and needed supplementary oxygen therapy, improved after treatment with nafamostat. These preliminary findings show the possibility th…
  • The Mental Health Burden of the COVID-19 Pandemic on Physical Therapists. [Journal Article]
    Int J Environ Res Public Health. 2020 May 25; 17(10)Yang S, Kwak SG, … Chang MC
  • We evaluated the mental health burden of coronavirus disease (COVID-19) on physical therapists, including their stress and anxiety levels, who were at risk of developing psychological distress and other mental health symptoms. A questionnaire survey was conducted with physical therapists of three university hospitals in South Korea on 10 April 2020. The questionnaires evaluated the presence of an…
  • Online Information Exchange and Anxiety Spread in the Early Stage of Novel Coronavirus Outbreak in South Korea. [Journal Article]
    J Med Internet Res. 2020 May 27 [Online ahead of print]Jo W, Lee J, … Kim Y
  • CONCLUSIONS: Search activity for online information regarding the COVID-19 outbreak has been active. Many of the online questions were related to people's anxieties and worries. A considerable portion of corresponding answers had false information or were advertisements. The study results could contribute reference information to various countries that need to monitor public anxiety and provide appropriate information in the early stage of an infectious disease outbreak, including COVID-19. Our research also contributes to developing methods for measuring public opinion and sentiment in an epidemic situation based on natural language data on the Internet.
  • Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. [Journal Article]
    N Engl J Med. 2020 May 27 [Online ahead of print]Goldman JD, Lye DCB, … GS-US-540-5773 Investigators
  • CONCLUSIONS: In patients with severe Covid-19 not requiring mechanical ventilation, our trial did not show a significant difference between a 5-day course and a 10-day course of remdesivir. With no placebo control, however, the magnitude of benefit cannot be determined. (Funded by Gilead Sciences; GS-US-540-5773 ClinicalTrials.gov number, NCT04292899.).
  • Compassionate use of hzVSF-v13 in two patients with severe COVID-19. [Letter]
    J Med Virol. 2020 May 26 [Online ahead of print]Kang CK, Choe PG, … Kim YW
  • We report the compassionate use of humanized Virus Suppressing Factor-variant 13 (hzVSF-v13) in two patients with severe coronavirus disease 2019 (COVID-19) pneumonia. Both patients, including an 81-year-old man who required extracorporeal membrane oxygenation, showed clinical improvement. These results warrant placebo-controlled trials to evaluate the hzVSF-v13 efficacy against COVID-19. This ar…
  • Comparing South Korea and Italy's healthcare systems and initiatives to combat COVID-19. [Journal Article]
    Rev Panam Salud Publica. 2020; 44:e53.Palaniappan A, Dave U, Gosine B
  • Italy and South Korea have two distinctly different healthcare systems, causing them to respond to public health crises such as the COVID-19 pandemic in markedly different ways. Differences exist in medical education for both countries, allowing South Korean medical graduates to have a more holistic education in comparison to their Italian counterparts, who specialize in medical education earlier…
New Search Next